The Food and Drug Administration today released for comment its first plan for advancing oversight of medical software based on artificial intelligence and machine learning.

“The plan outlines a holistic approach based on total product lifecycle oversight to further the enormous potential that these technologies have to improve patient care while delivering safe and effective software functionality that improves the quality of care that patients receive,” said Bakul Patel, director of the digital health center at FDA’s Center for Devices and Radiological Health. “To stay current and address patient safety and improve access to these promising technologies, we anticipate that this action plan will continue to evolve over time.”

Related News Articles

Headline
The Administration for Strategic Preparedness and Response May 15 announced it is launching four pharmaceutical manufacturing projects using artificial…
Headline
In this conversation, Aaron Lewandowski, M.D., emergency medicine physician and the emergency medicine stroke representative at Henry Ford West Bloomfield…
Headline
Cleveland Clinic's Eric Boose, M.D., family medicine physician and associate chief medical information officer and Rohit Chandra, executive vice president and…
Headline
The National Institutes of Health April 3 released a study that found an artificial intelligence screening tool was as effective as health care providers in…
Perspective
Public
America’s hospitals and health systems are incubators of innovation, ideas and medical progress as they are constantly striving to improve patient care and…
Headline
A ChatGPT vulnerability identified last year is being used by cyberthreat actors to attack security flaws in artificial intelligence systems, according to a…